Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,181
| Closed | -$1.19M | – | 318 |
|
|
2024
Q4 | $1.19M | Sell |
5,181
-1,198
| -19% | -$288K | 0.36% | 71 |
|
|
2024
Q3 | $1.56M | Buy |
6,379
+1,728
| +37% | +$386K | 0.28% | 73 |
|
|
2024
Q2 | $890K | Buy |
4,651
+3,669
| +374% | +$744K | 0.14% | 96 |
|
|
2024
Q1 | $194K | Buy |
982
+167
| +20% | +$30.6K | 0.02% | 239 |
|
|
2023
Q4 | $140K | Buy |
815
+393
| +93% | +$60.4K | 0.01% | 265 |
|
|
2023
Q3 | $62K | Sell |
422
-408
| -49% | -$73.8K | 0.01% | 312 |
|
|
2023
Q2 | $181K | Hold |
830
| – | – | 0.01% | 257 |
|
|
2023
Q1 | $182K | Buy |
830
+154
| +23% | +$33.4K | 0.01% | 235 |
|
|
2022
Q4 | $141K | Hold |
676
| – | – | 0.01% | 233 |
|
|
2022
Q3 | $148K | Hold |
676
| – | – | 0.01% | 235 |
|
|
2022
Q2 | $142K | Hold |
676
| – | – | 0.01% | 271 |
|
|
2022
Q1 | $164K | Buy |
676
+254
| +60% | +$61.4K | 0.01% | 254 |
|
|
2021
Q4 | $110K | Hold |
422
| – | – | ﹤0.01% | 255 |
|
|
2021
Q3 | $111K | Sell |
422
-140
| -25% | -$38.3K | ﹤0.01% | 253 |
|
|
2021
Q2 | $139K | Hold |
562
| – | – | 0.01% | 222 |
|
|
2021
Q1 | $109K | Hold |
562
| – | – | ﹤0.01% | 243 |
|
|
2020
Q4 | $119K | Buy |
562
+113
| +25% | +$22.5K | 0.01% | 228 |
|
|
2020
Q3 | $77K | Buy |
+449
| New | +$82.9K | ﹤0.01% | 248 |
|
|
2019
Q4 | – | Sell |
-15,295
| Closed | -$2.07M | – | 128 |
|
|
2019
Q3 | $2.07M | Sell |
15,295
-30,762
| -67% | -$4.03M | 0.13% | 81 |
|
|
2019
Q2 | $5.62M | Sell |
46,057
-8,454
| -16% | -$936K | 0.31% | 67 |
|
|
2019
Q1 | $5.67M | Buy |
+54,511
| New | +$5.63M | 0.29% | 73 |
|
|
2017
Q2 | – | Sell |
-58,612
| Closed | -$4.22M | – | 141 |
|
|
2017
Q1 | $4.22M | Sell |
58,612
-68,176
| -54% | -$4.71M | 0.16% | 84 |
|
|
2016
Q4 | $7.87M | Sell |
126,788
-253,543
| -67% | -$15.5M | 0.32% | 68 |
|
|
2016
Q3 | $24.6M | Sell |
380,331
-492,950
| -56% | -$32.8M | 0.89% | 46 |
|
|
2016
Q2 | $55.2M | Sell |
873,281
-311,999
| -26% | -$18.4M | 2.21% | 14 |
|
|
2016
Q1 | $68.5M | Buy |
1,185,280
+114,759
| +11% | +$6.5M | 2.7% | 7 |
|
|
2015
Q4 | $57.5M | Sell |
1,070,521
-33,071
| -3% | -$1.86M | 2.48% | 10 |
|
|
2015
Q3 | $56.2M | Buy |
1,103,592
+424,373
| +62% | +$22.8M | 2.2% | 17 |
|
|
2015
Q2 | $38.3M | Buy |
+679,219
| New | +$42.9M | 1.4% | 29 |
|
Other funds holding RMD
TOBAM's RMD Position: Q1 2025 in Review
TOBAM sold out of ResMed (RMD) in Q1 2025, closing a stake of 5,181 shares — an estimated $1.19M sold.
TOBAM first reported a position in RMD in Q2 2015 and held it in 29 quarters. The position peaked at $68.5M in Q1 2016. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.
- TOBAM reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
- TOBAM sold 5,181 ResMed shares in Q1 2025, an estimated $1.19M.
- TOBAM first reported a position in ResMed in Q2 2015 and held it in 29 quarters.
- TOBAM's ResMed position peaked at $68.5M in Q1 2016.
- 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.
Based on TOBAM's 13F filing for Q1 2025, filed 16 Apr 2025.